STAND. COM. REP. NO.727
Honolulu, Hawaii
, 2001
RE: H.B. No. 646
H.D. 1
Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twenty-First State Legislature
Regular Session of 2001
State of Hawaii
Sir:
Your Committee on Judiciary and Hawaiian Affairs, to which was referred H.B. No. 646 entitled:
"A BILL FOR AN ACT RELATING TO THE SALE OF STERILE SYRINGES FOR THE PREVENTION OF DISEASE,"
begs leave to report as follows:
The purpose of this bill is to decriminalize the sale of sterile syringes to persons who may use them for the injection of illicit drugs. More specifically, this bill:
(1) Authorizes pharmacists, physicians, health care providers, and authorized agents of a pharmacy or health care institution to sell sterile hypodermic syringes in a pharmacy, physician's office, or health care institution;
(2) Requires sellers to make available written educational material approved by the Department of Health (DOH) about the prevention of blood-borne diseases, drug treatment, and the safe disposal of used syringes at sites where syringes are sold;
(3) Provides that the sale of sterile hypodermic syringes, as authorized above, not constitute an offense under Section 329-43.5, Hawaii Revised Statutes (class C felony); and
(4) Requires the DOH to produce and make available written educational material about prevention of blood-borne diseases, drug treatment, and safe disposal of used syringes for distribution by sellers at the time syringes are sold.
Supportive testimony was submitted by DOH; Hawaii Medical Association; Hawaii Pharmacists Association; Department of Public Health Sciences and Epidemiology at the John A. Burns School of Medicine, University of Hawaii; AIDS Community Care Team; Hawaii HIV Prevention Community Planning Group; Association of Professionals in Infection Control and Epidemiology, Inc.; Community Health Outreach Work to Prevent AIDS; Life Foundation; Drug Policy Forum of Hawaii; Governor's Committee on HIV/AIDS; Gregory House Programs; and Hawaii Nurses Association.
Testimony in opposition to this measure was submitted by the Department of the Prosecuting Attorney of the City and County of Honolulu and the Honolulu Police Department.
Your Committee acknowledges that the sharing of hypodermic needles poses a significant health hazard to the citizens of our State. This practice has been proven to be a major cause of the spread of HIV, hepatitis B, hepatitis C, and other fatal diseases. Proponents of the bill have argued that by making sterile syringes accessible, the need to share hypodermic needles will be diminished, thus reducing the proliferation of communicable diseases.
After careful consideration, your Committee has amended the bill by:
(a) DOH has enough time to develop and implement systems to track syringes and for used syringe disposal prior to the start of the program; and
(b) The Legislature has an opportunity to reexamine the effectiveness of the program and its consequences;
and
As affirmed by the record of votes of the members of your Committee on Judiciary and Hawaiian Affairs that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 646, as amended herein, and recommends that it pass Third Reading in the form attached hereto as H.B. No. 646, H.D. 1.
Respectfully submitted on behalf of the members of the Committee on Judiciary and Hawaiian Affairs,
____________________________ ERIC G. HAMAKAWA, Chair |
||